Table II.
Irbesartan | Control | |||||
---|---|---|---|---|---|---|
Baseline | 3 Month | P Value | Baseline | 3 Month | P Value | |
SBP, mm Hg | 150±18 | 129±25 | .001 | 145±23 | 147±22 | ns |
DBP, mm Hg | 88±11 | 81±12 | .003 | 89±13 | 87±16 | ns |
IMT, mm | 1.06±.34 | 1.04±.30 | .225 | 1.00±.46 | .97±.52 | ns |
CFR | 2.87±.42 | 3.78±.32 | .0001 | 2.94±.61 | 3.06±.72 | ns |
LVMI, g/m2 | 135±35 | 131±37 | ns | 134±29 | 132±33 | ns |
Abbreviations: CFR, coronary flow velocity reserve; DBP, diastolic 24‐h ambulatory blood pressure; IMT, intima‐media thickness; LVMI, left ventricular mass index; ns, not significant; SBP, systolic 24‐h ambulatory blood pressure.